← Back
Thermo Fisher Scientific
TMO · listed on the New York Stock Exchange · worth $257.71 billion
$697.00
−1.72% on Oct 30
No insider bought Thermo Fisher Scientific stock in the last year. They sold it 79 times, $132.22 million in all. Six members of Congress reported trading Thermo Fisher Scientific in the last year.
Red dot = an insider soldA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
369.1M shares
100% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, six insiders sold Thermo Fisher Scientific stock and none bought. 61 of the 79 sales are marked on the filing as planned in advance; all by company executives. The biggest seller was Michel Lagarde, Executive Vice President & COO.
Planned sales
Form 144 notices filed for Thermo Fisher Scientific in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
Executive Lisa P. Britt filed to sell 2,831 shares on 28 Oct; sold 2,831 by 28 OctNotice on SEC.gov
COO Gianluca Pettiti filed to sell 4,133 shares on 31 Aug; no sale reported yet10b5-1 plan adopted 2 Jun 2026 · Notice on SEC.gov
CEO Marc N. Casper filed to sell 275 shares on 24 Aug; sold 10,275 by 24 Aug, more than the notice named10b5-1 plan adopted 27 Apr 2026 · Notice on SEC.gov
US Congress
Members of Congress who reported trading Thermo Fisher Scientific in the last year. They have up to 45 days to report, so the newest trades show up late.
MemberTradeAmountWhose accountTradedReported
All reports
Every insider trade and SEC report we hold for Thermo Fisher Scientific.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Aug 26SoldMarc N. CasperAug 26 · Traded Aug 24 · Chairman & CEO · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.62 @ $628.74$39K
Aug 26SoldMarc N. CasperAug 26 · Traded Aug 24 · Chairman & CEO · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.79 @ $628.01$49.6K
Aug 26SoldMarc N. CasperAug 26 · Traded Aug 24 · Chairman & CEO · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.33 @ $626.59$20.7K
Aug 26SoldMarc N. CasperAug 26 · Traded Aug 24 · Chairman & CEO · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.101 @ $625.41$63.2K
123 more with Pro →Analysts, earnings and news
Analysts' price target
$599.19 average
26 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
4 of 4 quarters above
Q1 '26$5.44 a share+$0.20
Q4 '25$6.57 a share+$0.12
Q3 '25$5.79 a share+$0.29
Q2 '25$5.36 a share+$0.13